Rapid COJEC versus standard induction therapies for high-risk neuroblastoma

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this study is to compare survival, treatment response and dose-limiting treatment-related severe adverse events in patients with high-risk neuroblastoma receiving induction therapy with either rapid COJEC or a standard schedule.